Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / ADS
-
Total 13F shares
-
3,488,801
-
Share change
-
+69,721
-
Total reported value
-
$6,974,000
-
Price per share
-
$2.00
-
Number of holders
-
9
-
Value change
-
+$161,027
-
Number of buys
-
3
-
Number of sells
-
5
Institutional Holders of ASLAN PHARMACEUTICALS LTD - ADS (ASLN) as of Q2 2020
As of 30 Jun 2020,
ASLAN PHARMACEUTICALS LTD - ADS (ASLN) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,488,801 shares.
The largest 9 holders included
Temasek Holdings (Private) Ltd, Sio Capital Management, LLC, PLATINUM INVESTMENT MANAGEMENT LTD, RENAISSANCE TECHNOLOGIES LLC, DAFNA Capital Management LLC, BANK OF MONTREAL /CAN/, MILLENNIUM MANAGEMENT LLC, MORGAN STANLEY, and UBS Group AG.
This page lists
9
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.